BusinessManufacturingTechnology

Boston Scientific Boosts Annual Profit Outlook on Robust Cardiac Device Sales

Boston Scientific has elevated its annual profit projections after exceeding third-quarter estimates, driven by substantial growth in heart device sales. The company’s electrophysiology segment saw a 23.1% year-over-year surge, with its stroke prevention and cardiac rhythm technologies performing particularly well. Despite facing regulatory and tariff challenges, the medical device manufacturer anticipates continued margin expansion.

Strong Cardiac Device Performance Drives Forecast Revision

Boston Scientific has reportedly raised its full-year profit guidance following better-than-expected third-quarter results, according to recent financial reports. The medical device manufacturer’s shares increased approximately 4.1% after the announcement, reflecting positive market response to the company’s performance and outlook.

AIScience

AI Unlocks Epigenetic Breakthroughs in Longevity Research

Scientists are harnessing AI to accelerate epigenetic research that could reverse aging processes. Harvard’s David Sinclair reports successful epigenetic resetting in mice, pointing to potential human applications within our lifetime.

AI Accelerates Epigenetic Aging Research

Artificial intelligence is revolutionizing how scientists approach epigenetics and aging research, with new breakthroughs suggesting age reversal might be achievable within our lifetimes, according to reports from leading researchers. Large language models and AI tools are helping scientists map the human genome and identify epigenetic processes that could slow or reverse aging, sources indicate.